Global Epigenetics Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth
Global Epigenetics Market is expected to reach the market valuation of USD XX million by 2027 expanding at a reasonable CAGR of XX% during the forecast period (2021-2027) from USD XX million in 2020. Epigenetics refers to the small and reversible modifications to DNA molecules that change the expression of genes without altering the sequence of DNA. It is the branch of genetics that focuses on processes that regulate the turning on and turning off of certain genes.
The various factors driving the growth of the epigenetics market include technological advancements, rising venture capital investment and increased partnerships & collaborations among major industry players. For instance, in June 2021, AstraZeneca and Proteros biostructures GmbH came into a collaboration to work jointly to develop cancer drugs that hit epigenetic targets. In addition to this, the increased funding for epigenetics projects by the government and private companies and institutes are further propelling the growth of the market.
For a detailed analysis of the epigenetics market browse through - https://univdatos.com/report/epigenetics-market
Furthermore, the rising incidences and mortality rate due to cancer is another significant factor responsible for the growth of the epigenetics market all over the world. For instance, as per the American Cancer Society, In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Also, with the growing interest of researchers for epigenetics research and the rise in funding for its research, the market is flourishing with numerous startups providing epigenetics solutions. For example, EpigenCare, a US-based startup that develops personal epigenomics tests. They offer a consumer biotech product, SKINTELLI that measures DNA methylation levels of genes that control aging, elasticity, moisture retention, and other factors of skin health.
However, some of the restraints in the market include concerns regarding the quality of antibodies and the lack of skilled professionals. Besides, the high cost of instruments is another factor impeding the growth of this market all over the world.
Based on products, the market is fragmented into enzymes, instruments, reagents, kits, and others. The kits segment dominated the market in 2020 and generated total revenue of USD XX million. The growth of this segment is attributed to the wide adoption of epigenetic solutions and the increase in the launch of new and advanced epigenetics kits by major industry players in the market. For example, in 2021, Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, launched a new small RNA-sequencing solution, D-Plex Small RNA DNBSEQ™ Kit, optimized and specifically formatted for MGI’s DNBSEQ sequencers.
For a detailed analysis of the market drivers of epigenetics market browse through - https://univdatos.com/report/epigenetics-market
Based on Application, the market is fragmented into oncology, metabolic diseases, cardiovascular diseases, immunology, developmental biology, and others. The oncology segment dominated the market in 2020 and generated total revenue of USD XX million. It is anticipated to maintain its dominance during the forecast period owing to the increasing prevalence of cancer coupled with the rising applications of epigenetics in biomarker identification. Furthermore, many key players in the market are focusing on epigenetic cancer research as the study of epigenetic modifications in cancer such as abnormal methylation pattern provides understandings of tumorigenic pathways, located above the genetic code.
Additionally, the report provides detailed initiatives that are being taken in the field of epigenetics. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to the increasing cancer incidence and higher government-funded initiatives. For instance, as per the GLOBOCON 2020, 22,81,658 new cancer cases and 6,12,390 deaths were reported in the United States. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.
Request for Sample of the report browse through - https://univdatos.com/request_form/form/491
Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, Diagenode are some of the prominent players operating in the global epigenetics market. Several M&A’s along with partnerships have been undertaken by these players to develop epigenetics solutions.
Global Epigenetics Market Segmentation
Market Insight, by Product
- DNA-modifying enzymes
- Protein-modifying enzymes
- RNA-modifying enzymes
- Next-generation Sequencers
- Mass spectrometers
- ChIP-sequencing kits
- RNA sequencing kits
- Bisulfite conversion kits
- Whole genome amplification kits
- 5-hmC & 5-mC analysis kits
- Magnetic beads
Market Insight, by Application
- Metabolic diseases
- Developmental Biology
- Cardiovascular diseases
Market Insight, by End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract research organizations (CROs)
Market Insight, by Region
- North America
- United States
- United Kingdom
- Rest of Europe
- Rest of Asia-Pacific
- Rest of World
Top Company Profiles
- Illumina Inc.
- Merck & Co.
- Abcam PLC
- Active Motif
- Thermo Fisher Scientific
- Agilent Technologies